Serotype of Streptococcus pneumoniae capsular polysaccharide can modify the Th1/Th2 cytokine profile and IgG subclass response to pneumococal-CRM(197) conjugate vaccines in a murine model.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Vaccine

• Publication date

  2000-12-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0264-410X(00)00314-5PMID 11137252
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid.

  1999cited by this paper
• B- and T-Cell Immune Responses to Pneumococcal Conjugate Vaccines: Divergence between Carrier- and Polysaccharide-Specific Immunogenicity

  1999cited by this paper
• Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers.

  1999cited by this paper
• Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine.

  1998cited by this paper
• Pneumococcal bacteraemia and meningitis in England and Wales, 1993 to 1995.

  1998cited by this paper
• Immunogenicity of Streptococcus pneumoniae type 6B and 14 polysaccharide-tetanus toxoid conjugates and the effect of uncoupled polysaccharide on the antigen-specific immune response.

  1998cited by this paper
• Safety and Immunogenicity of Heptavalent Pneumococcal Vaccine Conjugated to CRM197 in United States Infants

  1998cited by this paper
• Immunogenicity of polysaccharides conjugated to peptides containing T- and B-cell epitopes

  1994cited by this paper
• Protection of infant mice from challenge with Streptococcus pneumoniae type 19F by immunization with a type 19F polysaccharide--pneumolysoid conjugate.

  1994cited by this paper
• A randomized comparison of three bivalent Streptococcus pneumoniae glycoprotein conjugate vaccines in young children: effect of polysaccharide size and linkage characteristics.

  1994cited by this paper
• Pneumococcal capsular polysaccharide-meningococcal outer membrane protein complex conjugate vaccines: immunogenicity and efficacy in experimental pneumococcal otitis media.

  1993cited by this paper
• Thymus-independent and thymus-dependent responses to polysaccharide antigens.

  1992cited by this paper
• Role of contact and soluble factors in the growth and differentiation of B cells by helper T cells.

  1992cited by this paper
• Antibody response to pneumococcal capsular polysaccharide vaccine in African children.

  1991cited by this paper
• Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines

  1991cited by this paper
• Polysaccharide-protein conjugates: a new generation of vaccines.

  1990cited by this paper
• A new murine CD4+ T cell subset with an unrestricted cytokine profile.

  1989cited by this paper
• Heterogeneity of cytokine secretion patterns and functions of helper T cells.

  1989cited by this paper
• Pneumococcal vaccine efficacy in selected populations in the United States.

  1986cited by this paper
• Natural and vaccine-related immunity to Streptococcus pneumoniae.

  1986cited by this paper
• Prevention of otitis media in children by pneumococcal vaccination.

  1985cited by this paper
• Long-Term Persistence of Antibody following Immunization with Pneumococcal Polysaccharide Vaccine 1

  1983cited by this paper
• Clinical studies of pneumococcal vaccines in infants. I. Reactogenicity and immunogenicity of two polyvalent polysaccharide vaccines.

  1981cited by this paper
• Mouse IgG3 antibodies are highly protective against infection with Streptococcus pneumoniae

  1981cited by this paper
• Pneumococcal vaccine and otitis media.

  1980cited by this paper
• Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates

  1980cited by this paper
• Pneumococcal polysaccharide immunization in infants and children.

  1978cited by this paper
• Subclass restriction of murine anti-carbohydrate antibodies.

  1978cited by this paper
• A NEW MOUSE IMMUNOGLOBULIN: IGG3

  1971cited by this paper
• ELECTROPHORETIC SEPARATION AND PROPERTIES OF MOUSE ANTIHAPTEN ANTIBODIES INVOLVED IN PASSIVE CUTANEOUS ANAPHYLAXIS AND PASSIVE HEMOLYSIS

  1964cited by this paper

• Antigen-driven Convergent Evolution of Polysaccharide-specific “DH-less” B Cells in Glycoconjugate Immunized Mice

  2024cites this paper
• In-cell depolymerization of polysaccharide antigens. Exploring the processing pathways of glycans and why some glycoconjugate vaccines are less effective than expected: A review.

  2023cites this paper
• Booster immunization with a fractional dose of Prevnar 13 affects cell-mediated immune response but not humoral immunity in CD-1 mice

  2021cites this paper
• A glycoside analog of mammalian oligomannose formulated with a TLR4-stimulating adjuvant elicits HIV-1 cross-reactive antibodies

  2021cites this paper
• Modulation of immune response and enhanced clearance of Salmonella typhi by delivery of Vi polysaccharide conjugate using PLA nanoparticles.

  2020cites this paper
• Recombinant KRAS G12D Protein Vaccines Elicit Significant Anti-Tumor Effects in Mouse CT26 Tumor Models

  2020cites this paper
• Serum alpha-mannosidase as an additional barrier to eliciting oligomannose-specific HIV-1-neutralizing antibodies

  2020cites this paper
• Immunogenicity Comparison of a Next Generation Pneumococcal Conjugate Vaccine in Animal Models and Human Infants.

  2019cites this paper
• 46 – Pneumococcal Conjugate Vaccine and Pneumococcal Common Protein Vaccines

  2018cites this paper
• Growth Hormone (GH) Deficient Mice With GHRH Gene Ablation Are Severely Deficient in Vaccine and Immune Responses Against Streptococcus pneumoniae

  2018cites this paper
• The effect of splenectomy on the levels of PCV‐13‐induced memory B‐ and T cells

  2018cites this paper
• Studies on pneumococcal polysaccharides and their effect on immune cells

  2017cites this paper
• Immunogenicity differences of a 15-valent pneumococcal polysaccharide conjugate vaccine (PCV15) based on vaccine dose, route of immunization and mouse strain.

  2017cites this paper
• Anti-Pneumococcal Vaccine-Induced Cellular Immune Responses in Post-Traumatic Splenectomized Individuals

  2017cites this paper
• Immune cell activation and cytokine release after stimulation of whole blood with pneumococcal C-polysaccharide and capsular polysaccharides.

  2016cites this paper
• Response on Pneumococcal Vaccine in Preterm Infants After Neutral and Acidic Oligosaccharides Supplementation

  2015cites this paper
• Development of a conjugate vaccine against invasive pneumococcal disease based on capsular polysaccharides coupled with PspA/family 1 protein of Streptococcus pneumoniae.

  2015cites this paper
• Human Infant Memory B Cell and CD4+ T Cell Responses to HibMenCY-TT Glyco-Conjugate Vaccine

  2015cites this paper
• 25 – Pneumococcal conjugate vaccine and pneumococcal common protein vaccines

  2013cites this paper
• Immunization with the conjugate vaccine Vi-CRM₁₉₇ against Salmonella typhi induces Vi-specific mucosal and systemic immune responses in mice.

  2012cites this paper
• Immune suppression induced by Vi capsular polysaccharide is overcome by Vi-DT conjugate vaccine.

  2012cites this paper
• Desenvolvimento e Avaliação da Resposta Imune Humoral de uma Vacina Anti-Pneumocócica Conjugada: Polissacarídeo Capsular Sorotipo 14 - Proteína de Superfície Pneumocócica A

  2011cites this paper
• Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines

  2011cites this paper
• Outer Membrane Protein Complex of Meningococcus Enhances the Antipolysaccharide Antibody Response to Pneumococcal Polysaccharide–CRM197 Conjugate Vaccine

  2011cites this paper
• Lactococcus lactis as an adjuvant and delivery vehicle of antigens against pneumococcal respiratory infections

  2010cites this paper
• Preparation and immunogenicity of capsular polysaccharide-surface adhesin A (PsaA) conjugate of Streptococcuspneumoniae.

  2010cites this paper
• Enhanced immune response to pneumococcal infection in malnourished mice nasally treated with heat‐killed Lactobacillus casei

  2009cites this paper
• Antigen processing of glycoconjugate vaccines; the polysaccharide portion of the pneumococcal CRM(197) conjugate vaccine co-localizes with MHC II on the antigen processing cell surface.

  2009cites this paper
• Role of antibodies and T cells in pigeon fanciers' lung

  2009cites this paper
• Memory B and T cell responses induced by serotype 4 Streptococcus pneumoniae vaccines: longitudinal analysis comparing responses elicited by free polysaccharide, conjugate and carrier.

  2009cites this paper
• Nasal Immunization with Lactococcus lactis Expressing the Pneumococcal Protective Protein A Induces Protective Immunity in Mice

  2008cites this paper
• Immunogenicity of bioactive magnetic nanoparticles: natural and acquired antibodies.

  2008cites this paper
• Mycobacterial glycoconjugates as vaccine candidates against tuberculosis.

  2008cites this paper
• Serotype-Specific Immune Unresponsiveness to Pneumococcal Conjugate Vaccine following Invasive Pneumococcal Disease

  2008cites this paper
• The human B cell response to a pneumococcal conjugate vaccine.

  2008cites this paper
• Antibody Responses to Immunization with Polysaccharide-specific Memory B-cell and Generation of Pneumococcal Serotype-specific and Age-dependent

  2007cites this paper
• Polyvalent 23 epitope polysaccharide pneumonia vaccine induced effective protection through strain-adapted effector mechanisms as demonstrated by the different cytokine responses in mice challenged with two different strains of Streptococcus pneumoniae.

  2007cites this paper
• Serotype-Specific and Age-Dependent Generation of Pneumococcal Polysaccharide-Specific Memory B-Cell and Antibody Responses to Immunization with a Pneumococcal Conjugate Vaccine

  2007cites this paper
• 4.31 – Bacterial Carbohydrate-Based Vaccines

  2007cites this paper
• The kinetics and phenotype of the human B‐cell response following immunization with a heptavalent pneumococcal‐CRM197 conjugate vaccine

  2006cites this paper
• Early life T cell responses to pneumococcal conjugates increase with age and determine the polysaccharide‐specific antibody response and protective efficacy

  2006cites this paper
• Immunomodulatory properties of meningococcal outer membrane vesicles.

  2006cites this paper
• H. pylori-infection and antibody immune response in a rural Tanzanian population

  2006cites this paper
• Vaccination: a way to address questions in behavioral and population ecology?

  2004cites this paper
• A murine model for the study of immune memory in response to pneumococcal conjugate vaccination.

  2004cites this paper
• Differential Regulation of IgG Anti-Capsular Polysaccharide and Antiprotein Responses to Intact Streptococcus pneumoniae in the Presence of Cognate CD4+ T Cell Help1

  2004cites this paper
• The Humoral Immune Response to Streptococcus pneumoniae

  2004cites this paper
• Development of a new oral vaccine against diphtheria and the study of its immunogenicity in mouse and man.

  2004cites this paper
• IgG subclass response to Helicobacter pylori and CagA antigens in children

  2003cites this paper
• CIRCULACION DEL NEUMOCOCO RELACIONADO A CAMBIOS EN LOS FACTORES CLIMÁTICOS EN LA PROVINCIA DE LA RIOJA

  2003cites this paper
• An eleven valent diphtheria and tetanus - conjugated pneumococcal vaccine : Immunogenicity and safety in Filipino infants

  2003cites this paper
• Antigen Processing of the Heptavalent Pneumococcal Conjugate Vaccine Carrier Protein CRM197 Differs Depending on the Serotype of the Attached Polysaccharide

  2003cites this paper
• Presence of Cognate CD 4 in the Streptococcus pneumoniae Intact Polysaccharide and Antiprotein Responses to Differential Regulation of IgG Anti-Capsular

  2003cites this paper
• Corbel Respiratory Challenge Bordetella pertussis Protection from Investigation of Role of Nitric Oxide in

  2002cites this paper
• Current State of Pneumococcal Vaccines

  2002cites this paper
• Investigation of Role of Nitric Oxide in Protection from Bordetella pertussis Respiratory Challenge

  2002cites this paper